Posted on

The Health Technology Assessment (HTA) Philippines invites interested researchers to to express interest and submit full proposals for accelerated HTA (aHTA) of selected topics under the 2026 Health Technology Assessment (HTA) Research Agenda [Accelerated HTA Track]

The following are the health technology topics for assessments to be funded under this call for Full Proposals:

aHTA Topics for Commissioning

  1. Leptospirosis rapid diagnostic test (RDT) for rapid, qualitative screening of leptospira antibodies in the adult population clinically suspected of leptospirosis
  2. Cabotegravir for HIV Pre-exposure prophylaxis
  3. Pembrolizumab for cervical cancer
  4. Pembrolizumab for melanoma
  5. Pegylated asparaginase for childhood acute lymphocytic leukemia

For interested researchers, kindly take note of the following important dates:

  • Deadline of expression of interest: 16 March 2026 (Monday)
  • Deadline for submission of requirements: 20 working days from the submission of the expression of interest

Submissions shall be sent to htaresearch@dost.gov.ph

Kindly see the call guide and terms of reference for more info:

Call guide:

[2026 aHTA Batch 1 Call Guide] Proposal Guidelines for aHTA Topics as of 11Mar2026Download

Terms of Reference:

[aHTA] Draft TOR as of Feb2025Download